4. Critical reviews of psychoactive substances

4.1 AB-CHMINACA

• Critical Review Report pdf, 979kb
• Expert Peer Review No.1 pdf, 513kb  Expert Peer Review No.2 pdf, 635kb
• Annex 1: Questionnaire Report pdf, 274kb 

4.2 5F-ADB

• Critical Review Report pdf, 850kb
• Expert Peer Review No.1 pdf, 512kb  Expert Peer Review No.2 pdf, 513kb
• Annex 1: Questionnaire Report pdf, 274kb 

4.3 4-fluoroamphetamine (4-FA)  

• Critical Review Report pdf, 1.29Mb
• Expert Peer Review No.1 pdf, 499kb Expert Peer Review No.2 pdf, 516kb
• Annex 1: Questionnaire Report pdf, 274kb 

4.4 AB-PINACA

• Critical Review Report pdf, 1.11Mb
• Expert Peer Review No.1 pdf, 515kb Expert Peer Review No.2 pdf, 507kb
• Annex 1: Questionnaire Report pdf, 274kb 

4.5 Ocfentanil

• Critical Review Report pdf, 655kb
• Expert Peer Review No.1 pdf, 502kb Expert Peer Review No.2 pdf, 399kb
• Annex 1: Questionnaire Report pdf, 411kb 

4.6 Furanyl fentanyl (Fu-F)

• Critical Review Report pdf, 775kb
• Expert Peer Review No.1 pdf, 399kb Expert Peer Review No.2 pdf, 403kb
• Annex 1: Questionnaire Report pdf, 381kb 

4.7 Acryloylfentanyl (Acrylfentanyl)

• Critical Review Report pdf, 973kb
• Expert Peer Review No.1 pdf, 399kb Expert Peer Review No.2 pdf, 363kb
• Annex 1: Questionnaire Report pdf, 272kb 

4.8 Carfentanil

• Pre-Review Report pdf, 1.00Mb
• Expert Peer Review No.1 (Revised) pdf, 527kb Expert Peer Review No.2 (Revised) pdf, 519kb
• Annex 1: Questionnaire Report pdf, 273kb 

4.9 4-fluoroisobutyrfentanyl (4-FIBF, pFIBF)

• Critical Review Report pdf, 961kb
• Expert Peer Review No.1 pdf, 400kb Expert Peer Review No.2 pdf, 400kb
• Annex 1: Questionnaire Report pdf, 378kb 

4.10 Tetrahydrofuranylfentanyl (THF-F)

• Critical Review Report pdf, 947kb
• Expert Peer Review No.1 pdf, 515kb Expert Peer Review No.2 pdf, 400kb
• Annex 1: Questionnaire Report pdf, 271kb 

4.11 UR-144

• Critical Review Report pdf, 993kb
• Expert Peer Review No.1 pdf, 372kb Expert Peer Review No.2 pdf, 517kb
• Annex 1: Questionnaire Report pdf, 410kb 

4.12 5F-PB-22

• Critical Review Report pdf, 949kb
• Expert Peer Review No.1 pdf, 511kb Expert Peer Review No.2 pdf, 510kb
• Annex 1: Questionnaire Report pdf, 273kb 

4.13 Etizolam

• Critical Review Report pdf, 942kb
• Expert Peer Review No.1 pdf, 508kb Expert Peer Review No.2 pdf, 593kb
• Annex 1: Questionnaire Report pdf, 273kb 

5. Pre-reviews of substances  

5.1 Pregabalin*

• Pre Review Report pdf, 1.24Mb
• Expert Peer Review No.1 pdf, 502kb Expert Peer Review No.2 pdf, 607kb
• Annex 1: Questionnaire Report pdf, 274kb 

5.2 Cannabidiol*

• Pre Review Report pdf, 1.11Mb
• Expert Peer Review No.1 pdf, 402kb Expert Peer Review No.2 pdf, 531kb
• Annex 1: Questionnaire Report pdf, 273kb 

5.3 Tramadol*

• Pre-Review Report pdf, 1.01Mb
• Expert Peer Review No.1 pdf, 525kb Expert Peer Review No.2 pdf, 522kb
• Annex 1: Questionnaire Report pdf, 274kb